Glucose addiction of cholangiocarcinoma: opportunities for therapeutic development
Variation in attributable fraction of hepatitis B virus and hepatitis C virus among primary liver cancer cases across mainland China: a systematic literature review and meta-analysis
The application of artificial intelligence-based tools in the management of hepatocellular carcinoma: current status and future perspectives
Technical tips for indocyanine green-guided minimally invasive anatomical liver resection
Epidemiological characteristics and precise prophylaxis and control of HBV-associated primary liver cancer
Application of multi-omics in hepatocellular carcinoma: new prospects for classification and precise diagnosis and treatment
Pathophysiology of liver cirrhosis and risk correlation between immune status and the pathogenesis of hepatocellular carcinoma
Integrating artificial intelligence into multidisciplinary evaluations of HCC: opportunities and challenges
Surveillance for patients at risk of hepatocellular carcinoma: how to improve its cost-effectiveness and expand the role of multidisciplinary tumor board?
The interaction effect between key autophagy-related biomarkers and HBV/HCV infections on the survival prognosis of hepatocellular carcinoma
HCC in MASLD: radiological appearance, diagnosis and treatment
Predicting microvascular invasion plus cytokeratin 19 expression positivity in hepatocellular carcinoma based on EOB-MRI using multitask deep learning
Screening for lipid metabolism-related genes and identifying the therapeutic potential of ACACA for ER stress-related progression in hepatocellular carcinoma
Importance of critical tumor features in multidisciplinary multi-parametric assessment of HCC
Functions and potential clinical applications of circular RNAs in hepatocellular carcinoma
Influence of the gut microbiota on the response to immunotherapy in hepatocellular carcinoma
The new era of cholangiocarcinoma treatment: application of nano-based drug delivery systems
Cancer stem cells in cholangiocarcinoma: emerging roles as therapeutic targets
Glucose metabolic dysregulation and oxidative stress in cholangiocarcinoma: molecular mechanisms, oncogenic drivers, and novel therapeutic targets
Burden of liver cancer in adolescents and young adults aged 15-49 years in China: a comprehensive analysis based on the Global Burden of Disease study (1990-2021)
The importance of patient fitness in expert and multidisciplinary multiparametric management of HCC: a narrative review
Oncolytic virus VG161 brings new hope for advanced HCC
Price threshold analysis of biomarker surveillance for hepatocellular carcinoma in Australia
Immune microenvironment and immunotherapy strategies in MAFLD-related hepatocellular carcinoma
Thermal ablation therapy for hepatocellular carcinoma: recurrence mechanisms and intervention strategies
The multiparametric therapeutic hierarchy: a multidisciplinary approach to HCC management
Artificial intelligence for enhancing decision-making in multidisciplinary tumor boards for HCC in China
A baseline-lymphocyte-subset nomogram for predicting severe immune-related adverse events in hepatocellular carcinoma patients receiving TACE plus immunotherapy
Functional cure of chronic hepatitis B virus infection: current therapeutic regimens